ABAugusta Basantes

Augusta Basantes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Augusta Basantes has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Case Report, Multiple Giant Spiroadenocylindromas in a Geriatric Patient

    by Augusta Basantes, Efraín Suárez, Lisseth Ramírez, Lorena Vaca, Eduardo Vergara, Camila Felix, Paola Caceres, Andrea Cueva, Lesly López, Yoselin Chamorro, et al.

    Brooke-Spiegler Syndrome (BSS) is a rare autosomal dominant genodermatosis with variable penetrance, which is characterized by maintaining a progressive association of generally benign cutaneous adnexal neoformations among themselves. cylindromas, spiroadenomas and trichoepitheliomas. Other less frequently involved are trichoblastomas, follicular cysts, and organoid nevi. There are multiple phenotypic variants of SBS, which share the same genotypic origin; due to the overlap of the different lesions between them at a clinical, pathological, and genetic level, of which the present clinical case maintains a variant form that is rare in an association of multiple giant spiroadenocylindromas in a geriatric patient [1-11].

  • Erythema Annulare Centrifugum Associated with Autoimmune Catamenial Dermatitis

    by Yoselin Chamorro, Myrian Ortega, Karen Lema, Augusta Basantes, Camila Felix, Andrea Cueva, Lesly López, Janyna Jaramillo, Paola Caceres

    Erythema Annulare Centrifugum can be considered today as a marker of multiple diseases; there are some reports that mention the presence of this skin pathology as an expression of autoimmune dermatitis due to progesterone. A case of erythema Annulare Centrifugum with recurrent evolution and difficult control is presented in a female patient in whom, after hormonal treatment, had a favorable response

  • A Swollen Red Leg: Sweet’s Syndrome

    by Andrea Cueva, Patricio Freire, Verónica Posso, Paola Caceres, Camila Felix, Janyna Jaramillo, Yoselin Chamorro, Augusta Basantes, Lesly López

    Neutrophillic dermatoses comprise a range of conditions where the hallmark is histologic infiltrate of neutrophils. Ranging from skin disorders such as acute generalised exanthematous pustulosis or subcorneal pustulosis (Sneddon Wilkinson) which affect the epidermis, the neutrophilic infiltrate can affect the dermal portion such as in Neutrophillic urticaria, Sweet’s syndrome, or eccrine neutrophilic hidradenitis, or it can affect both epidermis and dermis such as in pyoderma gangrenosum. Many times the diagnosis of a neutrophilic dermatosis poses a challenge as the main differential are infectious diseases and a high degree of suspicion needed. Generally, the diagnosis is reached with clinical and dermatopathology correlation. We present the case of an 87-year-old woman with swollen red leg in whom the diagnosis posed a challenge

  • Disseminated Fusarium spp. Infection in an Immunocompromised Patient

    by Camila Felix, Franklin Cabrera, Verónica Posso, Paola Caceres, Andrea Cueva, Lesly López, Janyna Jaramillo, Yoselin Chamorro, Augusta Basantes

    Fusarium infections are rare opportunistic mycosis caused by Fusarium spp. Its clinical presentation depends on the immunological status of the host; those immunosuppressed hemato-oncological diseases can present invasive fungal. Diagnosis is through Skin or blood culture and it is treated with antifungal medication such as amphotericin B and voriconazole alone or in combination. We present the case of a neutropenic 55-year-old woman undergoing chemotherapy treatment for B-cell acute lymphoblastic leukemia who presented disseminated skin lesions which included macules, papules and violaceous nodules, with a central necrotic crust. A skin biopsy, KOH exam, tissue and blood cultures were carried out where Fusarium spp. were identified. Treatment with amphotericin b combined with voriconazole was initiated, with good results and complete disappearance of the lesions.

  • Trichilemmal Carcinoma: A Diagnostic Challenge Case Report

    by Paola Caceres, Franklin Cabrera, Verónica Posso, Augusta Basantes, Camila Felix, Andrea Cueva, Lesly López, Janyna Jaramillo, Yoselin Chamorro

    Trichilemmal carcinoma is a rare cutaneous tumor, representing only 1% of all adnexal carcinomas. It derives from the outer root sheath of the hair follicle. Clinically, it manifests as a skin-colored or slightly pink papule in sun-exposed areas in elderly patients. The following is a case report detailing trichilemmal carcinoma arising from a previous lesion and its correlation with histopathology

  • Open Access

    Diferencias Entre las Modalidades Terapéuticas y su Recurrencia en el Carcinoma Basocelular

    by Patricio Oswaldo Freire Murgueytio, Paola Stephanie Cáceres Andrade, María Augusta Basantes Orbea

    El cáncer de piel es el tumor más común, siendo el carcinoma basocelular el más frecuente. Es un tumor de crecimiento lento que se produce principalmente en la piel fotoexpuesta, con un porcentaje bajo de metástasis. Pero, si no es tratado a tiempo puede llegar ser destructivo e incluso desfigurar la anatomía si el tratamiento se retrasa.1 La incidencia mundial para el año 2000 fue de 93.1 y 77.4 por 100000 hombres y mujeres respectivamente.2 Según las últimas estadísticas la incidencia del CBC en la población europea oscila entre 77 y 158 por 100 000 habitantes por año, mientras en que en Estados Unidos, se considera una cifra que va entre los 226 a 362 por cada 100.000 habitantes por año.3 En Ecuador, según las últimas estadísticas, la incidencia acumulada de cáncer de piel no melanoma es de 16.56 por cada 100.000 habitantes, de los cuales, el carcinoma basocelular ocupa el primer puesto con 11.82 por 100.000 habitantes 4. Por lo tanto, además de conocer los diferentes métodos terapéuticos que existen para este tipo de tumor, es importante determinar los factores condicionantes para elegir el más apropiado de acuerdo con el tipo de paciente y su riesgo de recurrencia en base al tratamiento elegido.